Skip to main content

Meet us

Virtual KOL Event on Multiple Myeloma and New Clinical Data

15. Oktober, 17:00 CEST/ 11:00 EDT
Präsentation

Annual World ADC San Diego

4. - 7. November
Präsentation

Deutsches Eigenkapitalforum

25. - 27. November
Präsentation

ASH Annual Meeting and Exposition

7. - 10. Dezember

    Upcoming Conferences & Presentations 2024

    EventDateLocation
    Virtual KOL Event on Multiple Myeloma and New Clinical Data
    15. Oktober, 17:00 CEST/ 11:00 EDT
    Annual World ADC San Diego
    4. - 7. November
    San Diego
    BIO-EUROPE
    4. - 6. November
    Stockholm
    Deutsches Eigenkapitalforum
    25. - 27. November
    Frankfurt
    ASH Annual Meeting and Exposition
    7. - 10. Dezember
    San Diego

    Past Conferences & Presentations 2024

    EventDateLocationDownload
    HUPO World Congress
    20. - 24. Oktober
    Dresden
    Festival of Biologics
    15. - 17. Oktober
    Basel
    16th Annual Healthcare Investor Conference
    10. Oktober
    London
    BioRN Annual Conference
    9. Oktober
    Heidelberg
    ADC Pharmacokinetics & Clinical Pharmacology Summit
    8. - 10. Oktober
    Boston
    21th International Myeloma Society Annual Meeting
    25. - 28. September
    Rio de Janeiro
    ADC Process Development Summit
    17. - 19. September
    Boston
    ESMO Congress
    13. - 17. September
    Barcelona
    LSX World Congress USA (merged with BioPharm America)
    11. - 12. September
    Boston
    ADC Pharma & Biotech Partnering Summit
    9. - 10. September
    Boston
    The Antibody Series 2024
    4. - 6. September
    Madeira
    International Symposium on Medicinal Chemistry
    1. - 5. September
    Rom
    EPS (European Peptide Symposium)
    25. - 30. August
    Florence
    GRC Natural Products and Bioactive Compounds
    28. Juli - 2. August
    Andover
    25th Conference on Global Summit on Analytical and Bioanalytical Techniques
    24. - 25. Juli
    Paris

    R&D Webinar: Developing Next Generation ADCs Targeting Hard to Treat Cancers

    Heidelberg Pharma will present new clinical data at an R&D webinar early next year.

    Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.